Stem Point Capital LP Portfolio Holdings

Stem Point Capital LP

  • $314 Billion
  • Q1 2025

Stem Point Capital LP has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $314 Billion distributed in 62 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Roivant Sciences Ltd. with a value of $26B, Syndax Pharmaceuticals Inc with a value of $19.6B, Scholar Rock Holding Corp with a value of $18.2B, Arcellx, Inc. with a value of $18B, and Merus N.V. with a value of $14.6B.

Examining the 13F form we can see an decrease of $86.9B in the current position value, from $401B to 314B.

Stem Point Capital LP is based out at New York, NY

Below you can find more details about Stem Point Capital LP portfolio as well as his latest detailed transactions.

Portfolio value $314 Billion
Healthcare: $279 Billion
ETFs: $16.6 Million

Stock Holdings Table Market Cap. of Under $50 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$35.9M
$5.07 Billion 1.62% of portfolio
1,190,579
Q1 2025 Added 258.18%

Summary

  • Portfolio
  • No. of Stocks 62
  • Current Value $314 Billion
  • Prior Value $401 Billion
  • Filing
  • Period Q1 2025
  • Filing Date May 15, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 24 stocks
  • Additional Purchases 12 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 14 stocks
Track This Portfolio

Track Stem Point Capital LP Portfolio

Follow Stem Point Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stem Point Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Stem Point Capital LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email